In Part 2 of our series on Meta’s “Segment Anything,” we dig into the model’s limitations, biased evaluations, unfair comparisons, and real-world challenges in medical imaging.

Is it really the breakthrough it's claimed to be, or just a well-packaged generalist?

Join me and my AI co-host Zora as we ask the tough questions and look beyond the hype.

#AI #SegmentAnything #ZorgAI #MedicalImaging #Zora